Provider
QP95-21 Update for New to Market Medical Drugs: triamcinolone acetonide injectable suspension (Xipere) and vutrisiran
Program effective Date: Dec 08, 2021
Documents & Forms Results
Displaying 1081 - 1090 of 3636 results
Provider
QP96-21 Processing Change for HCPCS Code A9279
Program effective Date: Dec 08, 2021
Provider
QP97-21 MHCP Pharmacy Benefit Exclusion for Asparlas™, Khapzory™, Nulojix®, Oncaspar® and Susvimo™
Program effective Date: Dec 08, 2021
Provider
QP98-21 Commercial Pharmacy Benefit Exclusion for Nulojix® and Susvimo™
Program effective Date: Dec 08, 2021
Provider
QP99-21 Blue Cross and Blue Shield of Minnesota Collaboration with VillageHealth
Program effective Date: Dec 08, 2021
Provider
QP100-21 Checks to be Sent for Unpaid Prompt Pay Penalties
Program effective Date: Dec 08, 2021
Provider
QP101-21 Commercial Pharmacy Benefit Update – Revised Drug-Related Prior Authorization (PA) Requirement Notification – Effective February 1, 2022
Program effective Date: Dec 08, 2021
Provider
2021 December Provider Press
Program effective Date: Dec 03, 2021